Quality HTA at ValleyML 2021
Quality HTA in ValleyML 2021 - Quality HTA is honoured to present AI in HTA. Pooyeh Graili, the principal consultant at Quality HTA, will talk about "Artificial Intelligence in Health Technology Assessment" on October 12, [...]
Quality HTA & HTAi Webinar
Quality HTA & HTAi Webinar - Quality HTA is honoured to contribute to holding a webinar "Artificial Intelligence in Outcomes Research" presenting by Pooyeh Graili, the principal consultant at Quality HTA, in the third [...]
Over 100 Viewers in Four Months!
Over 100 Viewers in Four Months - Quality HTA is honored with its last article, "Artificial intelligence in outcomes research: a systematic scoping review" published four months ago by Expert Rev Pharmacoecon Outcomes Res [...]
CADTH & Advisory Panel for a Pan-Canadian Prescription List
CADTH & Advisory Panel for a Pan-Canadian Prescription Drug List - CADTH was chosen to establish the Advisory Panel to develop a framework for a pan-Canadian prescription drug list. CADTH will provide this service [...]
Only One Submission at the EU level!
Only One Submission at the EU level! The joint clinical assessment of new health technologies is a valuable step to accelerate patients' access to new health technologies, manufacturers' access to the market and increase [...]
Artificial Intelligence in the Regulatory Processes
Artificial Intelligence in the Regulatory Processes - Artificial intelligence can accelerate the drug development process and reduce its cost by virtual screening new molecules and optimizing patient recruitment in trials. Artificial intelligence can accelerate [...]
The Challenges of Regulatory & HTA Bodies in RWE
The Challenges of Regulatory and HTA Bodies in RWE - An interesting qualitative article by Silvers H. et al. about the perspectives on challenges, values & alignment of regulatory and HTA bodies. Great findings which [...]
Artificial Intelligence in Outcomes Research
Artificial Intelligence in Outcomes Research - Quality HTA is pleased to announce its recent paper “Artificial Intelligence in Outcomes Research: A Systematic Scoping Review” published online by the Expert Review of Pharmacoeconomics & Outcomes [...]
The Impact of COVID-19 on HTA
The Impact of COVID-19 on HTA - Regulation bodies and HTA agencies might need to use RWE more than ever and/or re-evaluate listed technologies using the RWE to cease reimbursement of low-value health technologies [...]
2021!
Happy 2021! Wishing you and your family a year full of health and happiness!